SYT1 and Alzheimer disease: Similarly, synaptotagmin-1 and growth-associated protein 43 (GAP 43) CSF concentrations have been shown to be increased in AD-disorders, thus representing a potential biomarker of synaptic degeneration in AD [79,83].